Dihydroimidazopyrazinone derivatives useful in the treatment of cancer

The present disclosure concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R

Saved in:
Bibliographic Details
Main Authors Swallow, Steven, Graham, Mark Andrew, McCabe, James Francis, Jones, Clifford David, Ward, Richard Andrew, Dobson, Andrew Hornby
Format Patent
LanguageEnglish
Published 30.05.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R
Bibliography:Application Number: AU20160351813